research use only
Cat.No.E0486
| Related Targets | PD-1/PD-L1 CXCR STING AhR Immunology & Inflammation related CD markers Interleukins Anti-infection Antioxidant COX |
|---|---|
| Other CCR Inhibitors | Cenicriviroc INCB3344 Vicriviroc Malate Adaptavir (DAPTA) ZK756326 2HCl BX471 (ZK-811752) RS102895 BMS-813160 SB-297006 R243 |
|
In vitro |
DMSO
: 150 mg/mL
(320.75 mM)
Ethanol : 23 mg/mL Water : Insoluble |
|
In vivo |
|||||
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.
| Molecular Weight | 467.65 | Formula | C27H41N5O2 |
Storage (From the date of receipt) | 3 years -20°C powder |
|---|---|---|---|---|---|
| CAS No. | 864289-85-0 | -- | Storage of Stock Solutions |
|
|
| Targets/IC50/Ki |
CCR4
(in the [35S]GTPγS-binding and mouse chemotaxis assay) 39 nM
CCR4
(in the [35S]GTPγS-binding and human chemotaxis assay) 0.14 μM
|
|---|---|
| In vivo |
C021 is a potent CC chemokine receptor-4 (CCR4) antagonist, which significantly reduces microglia activation and phosphorylation of ERK1/2, also alleviates AOM-induced cytokine upregulation in azoxymethane (AOM)-treated mice. |
References |
|
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.